InsidersTradesSigma
Follow the Bioceltix S.A. stock price and the full insider trade history of the company, a publicly traded company based in Poland. Shares are quoted on the PL market, under the oversight of KNF. Operating in the Health Care sector, Bioceltix S.A. has published 1 public disclosures. Market capitalisation: €445.9m. The latest transaction was filed on 18 May 2026 (Notification PDMR). All data is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bioceltix S.A. Strong Buy (bullish), based on 1 analysts. Average price target: PLN 133.00.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 May 2026
关于 Bioceltix S.A.
Bioceltix S.A. 是一家专注于健康和制药领域的公司。该公司在 XWAR 市场上市。